102 related articles for article (PubMed ID: 26112722)
21. Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma.
Zhong JH; Ke Y; Gong WF; Xiang BD; Ma L; Ye XP; Peng T; Xie GS; Li LQ
Ann Surg; 2014 Aug; 260(2):329-40. PubMed ID: 24096763
[TBL] [Abstract][Full Text] [Related]
22. Glypican-3 is a potential prognostic biomarker for hepatocellular carcinoma after curative resection.
Fu SJ; Qi CY; Xiao WK; Li SQ; Peng BG; Liang LJ
Surgery; 2013 Sep; 154(3):536-44. PubMed ID: 23601901
[TBL] [Abstract][Full Text] [Related]
23. Low serum interleukin-6 levels as a predictive marker of recurrence in patients with hepatitis B virus related hepatocellular carcinoma who underwent curative treatment.
Cho HJ; Kim SS; Ahn SJ; Park SY; Park JH; Kim JK; Wang HJ; Cheong JY; Cho SW
Cytokine; 2015 Jun; 73(2):245-52. PubMed ID: 25797190
[TBL] [Abstract][Full Text] [Related]
24. [Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm].
Yang MJ; An SY; Moon EJ; Lee MS; Hwang JA; Cheong JY; Won JH; Kim JK; Wang HJ; Cho SW
Korean J Hepatol; 2009 Dec; 15(4):474-85. PubMed ID: 20037266
[TBL] [Abstract][Full Text] [Related]
25. Vascular invasion in hepatocellular carcinoma: prevalence, determinants and prognostic impact.
Lee YH; Hsu CY; Huang YH; Hsia CY; Chiou YY; Su CW; Lin HC; Huo TI
J Clin Gastroenterol; 2014 Sep; 48(8):734-41. PubMed ID: 24100755
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors for long-term outcome after percutaneous thermal ablation for hepatocellular carcinoma: a survival analysis of 137 consecutive patients.
Xu HX; Lu MD; Xie XY; Yin XY; Kuang M; Chen JW; Xu ZF; Liu GJ
Clin Radiol; 2005 Sep; 60(9):1018-25. PubMed ID: 16124984
[TBL] [Abstract][Full Text] [Related]
27. Nationwide study of 4741 patients with non-B non-C hepatocellular carcinoma with special reference to the therapeutic impact.
Utsunomiya T; Shimada M; Kudo M; Ichida T; Matsui O; Izumi N; Matsuyama Y; Sakamoto M; Nakashima O; Ku Y; Kokudo N; Makuuchi M;
Ann Surg; 2014 Feb; 259(2):336-45. PubMed ID: 23673768
[TBL] [Abstract][Full Text] [Related]
28. High serum des-gamma-carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma.
Kobayashi M; Ikeda K; Kawamura Y; Yatsuji H; Hosaka T; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Saitoh S; Arase Y; Kumada H
Cancer; 2009 Feb; 115(3):571-80. PubMed ID: 19117347
[TBL] [Abstract][Full Text] [Related]
29. Do young hepatocellular carcinoma patients with relatively good liver function have poorer outcomes than elderly patients?
Cho SJ; Yoon JH; Hwang SS; Lee HS
J Gastroenterol Hepatol; 2007 Aug; 22(8):1226-31. PubMed ID: 17498220
[TBL] [Abstract][Full Text] [Related]
30. Does postembolization fever after chemoembolization have prognostic significance for survival in patients with unresectable hepatocellular carcinoma?
Shim JH; Park JW; Choi JI; Kim HB; Lee WJ; Kim CM
J Vasc Interv Radiol; 2009 Feb; 20(2):209-16. PubMed ID: 19084432
[TBL] [Abstract][Full Text] [Related]
31. The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma.
Dhanasekaran R; Khanna V; Kooby DA; Spivey JR; Parekh S; Knechtle SJ; Carew JD; Kauh JS; Kim HS
J Vasc Interv Radiol; 2010 Aug; 21(8):1197-204; quiz 204. PubMed ID: 20656222
[TBL] [Abstract][Full Text] [Related]
32. Do young hepatocellular carcinoma patients have worse prognosis? The paradox of age as a prognostic factor in the survival of hepatocellular carcinoma patients.
Chen CH; Chang TT; Cheng KS; Su WW; Yang SS; Lin HH; Wu SS; Lee CM; Changchien CS; Chen CJ; Sheu JC; Chen DS; Lu SN
Liver Int; 2006 Sep; 26(7):766-73. PubMed ID: 16911457
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B virus reactivation after radiofrequency ablation or hepatic resection for HBV-related small hepatocellular carcinoma: a retrospective study.
Dan JQ; Zhang YJ; Huang JT; Chen MS; Gao HJ; Peng ZW; Xu L; Lau WY
Eur J Surg Oncol; 2013 Aug; 39(8):865-72. PubMed ID: 23597497
[TBL] [Abstract][Full Text] [Related]
34. Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial.
Peng ZW; Zhang YJ; Liang HH; Lin XJ; Guo RP; Chen MS
Radiology; 2012 Feb; 262(2):689-700. PubMed ID: 22157201
[TBL] [Abstract][Full Text] [Related]
35. Elevated serum vitamin B(12) levels in association with tumor markers as the prognostic factors predictive for poor survival in patients with hepatocellular carcinoma.
Lin CY; Kuo CS; Lu CL; Wu MY; Huang RF
Nutr Cancer; 2010; 62(2):190-7. PubMed ID: 20099193
[TBL] [Abstract][Full Text] [Related]
36. Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ≤3 cm. Results of a multicenter Italian survey.
Pompili M; Saviano A; de Matthaeis N; Cucchetti A; Ardito F; Federico B; Brunello F; Pinna AD; Giorgio A; Giulini SM; De Sio I; Torzilli G; Fornari F; Capussotti L; Guglielmi A; Piscaglia F; Aldrighetti L; Caturelli E; Calise F; Nuzzo G; Rapaccini GL; Giuliante F
J Hepatol; 2013 Jul; 59(1):89-97. PubMed ID: 23523578
[TBL] [Abstract][Full Text] [Related]
37. Survival in patients with recurrent hepatocellular carcinoma after primary hepatectomy: comparative effectiveness of treatment modalities.
Ho CM; Lee PH; Shau WY; Ho MC; Wu YM; Hu RH
Surgery; 2012 May; 151(5):700-9. PubMed ID: 22284764
[TBL] [Abstract][Full Text] [Related]
38. Combined resection with radiofrequency ablation for bilobar hepatocellular carcinoma: a single-center experience.
Zhang T; Zeng Y; Huang J; Liao M; Wu H
J Surg Res; 2014 Oct; 191(2):370-8. PubMed ID: 24766727
[TBL] [Abstract][Full Text] [Related]
39. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma.
Kinoshita A; Onoda H; Imai N; Iwaku A; Oishi M; Tanaka K; Fushiya N; Koike K; Nishino H; Matsushima M
Ann Surg Oncol; 2015 Mar; 22(3):803-10. PubMed ID: 25190127
[TBL] [Abstract][Full Text] [Related]
40. Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma.
Peng ZW; Zhang YJ; Chen MS; Liang HH; Li JQ; Zhang YQ; Lau WY
Surg Oncol; 2008 Jul; 17(1):23-31. PubMed ID: 17869095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
